|
Real-time Estimate
Cboe BZX
14:20:10 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 2.615 USD | +0.97% |
|
+1.53% | +47.22% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 11 | +324.71% | 2 | |||||
| 1,315.04 | +13.36% | 29 | ||||||
| 275.64 | +0.15% | 22 | ||||||
| 276.59 | +5.68% | 29 | ||||||
| 370.31 | +6.04% | 18 | ||||||
| 154.4 | -4.45% | 21 | ||||||
| 212.68 | +31.5% | 22 | ||||||
| 388.48 | -12.27% | 29 | ||||||
| 309.73 | +2.68% | 23 | ||||||
| 157.41 | +5.21% | 27 | ||||||
| 28.61 | -1.43% | 26 | ||||||
| 569.54 | +2.3% | 26 | ||||||
| 66.21 | -2.15% | 24 | ||||||
| 94.28 | +22.19% | 23 | ||||||
| 21.69 | +16.51% | 20 | ||||||
| 9,323.33 | +36.47% | 15 | ||||||
| 6,559.56 | +12.63% | 16 | ||||||
| 57.39 | +16.69% | 18 | ||||||
| 71.35 | +56.58% | 17 | ||||||
| 4.211 | +15.06% | 17 | ||||||
| Average | 1,013.37 | +27.37% | 21 | ||||||
| Weighted average by Cap. | 701.99 | +7.59% | 24 |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
